Future Directions of Drug-Eluting Stents |
| |
Authors: | NEVILLE KUKREJA M.A. M.R.C.P. YOSHINOBU ONUMA M.D. PATRICK W. SERRUYS M.D. Ph .D. |
| |
Affiliation: | From the Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands |
| |
Abstract: | Coronary artery stents have changed the face of interventional cardiology since their introduction in 1986. The commercial release of drug-eluting stents in 2002 promised to abolish in-stent restenosis as the predominant clinical limitation following stent implantation. Concerns raised about increased risks of adverse events with drug-eluting stents now appear unfounded but have heralded a new era of research, where only hard clinical end-points in sufficiently large numbers of patients are considered adequate. In this review, we highlight some of the potential future directions of drug-eluting stents including specialized stent platforms (including dedicated bifurcation stents), fully degradable stents, and the potential use of stents to prevent cardiac events. |
| |
Keywords: | |
|
|